Literature DB >> 32743974

Defeatist performance beliefs in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.

Kendall B Clay1, Ian M Raugh1, Lisa A Bartolomeo1, Gregory P Strauss1.   

Abstract

AIM: Prior studies indicate that defeatist performance beliefs (DPBs) are elevated in those in the chronic phase of schizophrenia (SZ) and associated with negative symptoms, functional outcome and neurocognitive impairment. However, it is unclear whether these same patterns of results hold in participants at clinical high-risk (CHR) for psychosis.
METHODS: Two studies were conducted to determine whether prior results in SZ could be replicated and extended to CHR. Participants included 184 healthy controls (CN) and 186 outpatients with chronic SZ for Study 1, and 30 CN and 35 CHR in Study 2. In both studies, participants completed the DPB scale and measures of negative symptoms, psychosocial functioning and neurocognition.
RESULTS: Both chronic SZ and CHR participants had elevated DPBs compared to CN (p's < .01). In SZ, higher DPBs were associated with greater negative symptoms (r's = .31-.37, p's < .01), poorer social functioning and impaired social cognition (r = -.40, P < .001). In CHR, greater DPBs were associated with poorer social functioning (r = -.52, P < .05) and impairments in the neurocognitive domains of reasoning (r = -.48, P < .05) and processing speed (r = -.41, P < .05). Models testing whether DPBs mediated links between negative symptoms and functioning, negative symptoms and cognition and cognition and functioning were nonsignificant in SZ and CHR samples.
CONCLUSIONS: Findings generally provide support for the cognitive model of negative symptoms and functioning and suggest that DPBs are an important clinical target across phases of psychotic illness.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  at-risk mental state; functional outcome; negative symptoms; prodrome; ultra high-risk

Year:  2020        PMID: 32743974     DOI: 10.1111/eip.13024

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  3 in total

1.  A Bioecosystem Theory of Negative Symptoms in Schizophrenia.

Authors:  Gregory P Strauss
Journal:  Front Psychiatry       Date:  2021-03-25       Impact factor: 4.157

2.  The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.

Authors:  Gregory P Strauss; Kelsey I Macdonald; Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Sydney H James
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-21       Impact factor: 5.270

Review 3.  Psychological Dimensions Relevant to Motivation and Pleasure in Schizophrenia.

Authors:  Samantha V Abram; Lauren P Weittenhiller; Claire E Bertrand; John R McQuaid; Daniel H Mathalon; Judith M Ford; Susanna L Fryer
Journal:  Front Behav Neurosci       Date:  2022-03-23       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.